Orthometrix's shock wave therapy:
This article was originally published in Clinica
Executive Summary
The US FDA has given Orthometrix approval to market its high-energy shock wave system for relieving chronic plantar fasciitis (foot pain). The Orbasone device, a small and compact product, creates shock waves by using a spark plug enclosed in a soft membrane-covered dome filled with water; the dome is placed against the heel. The physician-supervised treatment typically takes about 30-40 minutes. The American Podiatric Medical Association in 2000 said that 38.6 million people in the US suffered from plantar fasciitis, noted the White Plains, New York-based firm. The Orbasone system is already cleared for sale in Europe, Asia and Canada.